{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:57:39Z","timestamp":1790758659274,"version":"4.1.0"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01ES034767"],"award-info":[{"award-number":["R01ES034767"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01ES033678"],"award-info":[{"award-number":["R01ES033678"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21ES03637"],"award-info":[{"award-number":["R21ES03637"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Anne Theodore Foundation Breakthrough Sarcoidosis Initiative"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>CD55 is an immune regulator that inhibits T-cell activation and also binds to CD97, a molecule involved in immune cell migration and signaling. While CD55 expression is reduced in chronic beryllium disease (CBD), its functional role in disease pathogenesis remains unclear. We hypothesized that CD55 downregulation in peripheral blood mononuclear cells (PBMCs) contributes to heightened beryllium (Be)\u2013specific immune responses in CBD. To test this, we characterized CD55 expression and function in PBMCs from patients with CBD and individuals with beryllium sensitization (BeS), as well as in a human Be-specific T-cell model. CD55, soluble CD55 (sCD55), and CD97 mRNA expression was quantified by qRT-PCR in PBMCs from CBD (n\u2009=\u200925), BeS (n\u2009=\u200936), and control (n\u2009=\u20097) participants. BeSO4 (beryllium sulfate) stimulation was used to assess CD55, STAT1, JAK2, and TNF-\u03b1 expression over time in CBD PBMCs (n\u2009=\u20098). Serum sCD55 was measured by ELISA in an independent cohort. Functional studies using anti-CD55 neutralizing antibodies and the JAK2 inhibitor TG101348 evaluated effects on TNF-\u03b1 production and lymphocyte proliferation (beryllium lymphocyte proliferation test [BeLPT]) in PBMCs, and IL-2 production in a Jurkat-Be cell model. CD55, sCD55, and CD97 were significantly downregulated in CBD PBMCs compared to BeS (P\u2009&amp;lt;\u2009.001). Serum sCD55 was also reduced in CBD (P\u2009&amp;lt;\u2009.05). BeSO4 stimulation further downregulated CD55 and upregulated STAT1. CD55 blockade increased TNF-\u03b1 production and BeLPT responses in CBD (P\u2009&amp;lt;\u2009.001) and BeS (P\u2009&amp;lt;\u2009.05); these effects were reversed by JAK2 inhibition. In the Be-cell model, CD55 inhibition enhanced IL-2 production (P\u2009&amp;lt;\u2009.01), attenuated by JAK2 blockade. These findings suggest that CD55 downregulation amplifies Be-induced immune responses in CBD via JAK2\/STAT1 signaling.<\/jats:p>","DOI":"10.1093\/ajrcmb\/aanag063","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T11:41:28Z","timestamp":1775648488000},"page":"1431-1439","source":"Crossref","is-referenced-by-count":0,"title":["Immune regulation by CD55 in chronic beryllium disease"],"prefix":"10.1093","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0692-6889","authenticated-orcid":false,"given":"Li","family":"Li","sequence":"first","affiliation":[{"name":"Division of Environmental and Occupational Health Sciences, Department of Medicine, National Jewish Health, Denver , Denver, CO,","place":["United States"]},{"name":"Division of Pulmonary and Critical Care Sciences, Department of Medicine, School of Medicine , University of Colorado\u2013Anschutz Medical Campus , Aurora, CO,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sucai","family":"Liu","sequence":"additional","affiliation":[{"name":"Division of Environmental and Occupational Health Sciences, Department of Medicine, National Jewish Health, Denver , Denver, CO,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Lei","sequence":"additional","affiliation":[{"name":"Division of Environmental and Occupational Health Sciences, Department of Medicine, National Jewish Health, Denver , Denver, CO,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Macaluso","sequence":"additional","affiliation":[{"name":"Division of Environmental and Occupational Health Sciences, Department of Medicine, National Jewish Health, Denver , Denver, CO,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujin","family":"Guo","sequence":"additional","affiliation":[{"name":"Division of Environmental and Occupational Health Sciences, Department of Medicine, National Jewish Health, Denver , Denver, CO,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristyn","family":"MacPhail","sequence":"additional","affiliation":[{"name":"Division of Environmental and Occupational Health Sciences, Department of Medicine, National Jewish Health, Denver , Denver, CO,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret M","family":"Mroz","sequence":"additional","affiliation":[{"name":"Division of Environmental and Occupational Health Sciences, Department of Medicine, National Jewish Health, Denver , Denver, CO,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara I","family":"Restrepo","sequence":"additional","affiliation":[{"name":"Division of Environmental and Occupational Health Sciences, Department of Medicine, National Jewish Health, Denver , Denver, CO,","place":["United States"]},{"name":"Division of Pulmonary and Critical Care Sciences, Department of Medicine, School of Medicine , University of Colorado\u2013Anschutz Medical Campus , Aurora, CO,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana Y","family":"Yang","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Sciences, Department of Medicine, School of Medicine , University of Colorado\u2013Anschutz Medical Campus , Aurora, CO,","place":["United States"]},{"name":"Department of Biomedical Informatics, School of Medicine, University of Colorado\u2013Anschutz Medical Campus , Aurora, CO,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A","family":"Maier","sequence":"additional","affiliation":[{"name":"Division of Environmental and Occupational Health Sciences, Department of Medicine, National Jewish Health, Denver , Denver, CO,","place":["United States"]},{"name":"Division of Pulmonary and Critical Care Sciences, Department of Medicine, School of Medicine , University of Colorado\u2013Anschutz Medical Campus , Aurora, CO,","place":["United States"]},{"name":"Department of Environmental and Occupational Health, Colorado School of Public Health, University of Colorado\u2013Anschutz Medical Campus , Aurora, CO,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,4,9]]},"reference":[{"key":"2026093004085558200_aanag063-B1","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1016\/j.chest.2020.07.074","article-title":"Chronic beryllium disease: update on a moving target","volume":"158","author":"MacMurdo","year":"2020","journal-title":"Chest"},{"key":"2026093004085558200_aanag063-B2","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s004200100237","article-title":"Beryllium sensitization and disease among long-term and short-term workers in a beryllium ceramics plant","volume":"74","author":"Henneberger","year":"2001","journal-title":"Int Arch Occup Environ Health"},{"key":"2026093004085558200_aanag063-B3","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1097\/00043764-200103000-00011","article-title":"Efficacy of serial medical surveillance for chronic beryllium disease in a beryllium machining plant","volume":"43","author":"Newman","year":"2001","journal-title":"J Occup Environ Med"},{"key":"2026093004085558200_aanag063-B4","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1289\/ehp.96104s5937","article-title":"The natural history of beryllium sensitization and chronic beryllium disease","volume":"104(Suppl 5)","author":"Newman","year":"1996","journal-title":"Environ Health Perspect"},{"key":"2026093004085558200_aanag063-B5","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1164\/rccm.200402-190OC","article-title":"Beryllium sensitization progresses to chronic beryllium disease: a longitudinal study of disease risk","volume":"171","author":"Newman","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"2026093004085558200_aanag063-B6","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.clim.2005.10.014","article-title":"Membrane complement regulatory proteins","volume":"118","author":"Kim","year":"2006","journal-title":"Clin Immunol"},{"key":"2026093004085558200_aanag063-B7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/s0022-1759(01)00519-1","article-title":"Distinct forms of DAF in urine and blood","volume":"260","author":"Miot","year":"2002","journal-title":"J Immunol Methods"},{"key":"2026093004085558200_aanag063-B8","doi-asserted-by":"publisher","first-page":"7464","DOI":"10.1038\/s41598-017-07791-8","article-title":"Bronchoalveolar lavage fluid protein expression in acute respiratory distress syndrome provides insights into pathways activated in subjects with different outcomes","volume":"7","author":"Bhargava","year":"2017","journal-title":"Sci Rep"},{"key":"2026093004085558200_aanag063-B9","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1126\/science.2466338","article-title":"Signal peptide for protein secretion directing glycophospholipid membrane anchor attachment","volume":"243","author":"Caras","year":"1989","journal-title":"Science (1979)"},{"key":"2026093004085558200_aanag063-B10","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1084\/jem.20041967","article-title":"Decay-accelerating factor modulates induction of T cell immunity","volume":"201","author":"Heeger","year":"2005","journal-title":"J Exp Med"},{"key":"2026093004085558200_aanag063-B11","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.expneurol.2004.06.005","article-title":"Complement regulators in extraocular muscle and experimental autoimmune myasthenia gravis","volume":"189","author":"Kaminski","year":"2004","journal-title":"Exp Neurol"},{"key":"2026093004085558200_aanag063-B12","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1172\/JCI16086","article-title":"Markedly enhanced susceptibility to experimental autoimmune myasthenia gravis in the absence of decay-accelerating factor protection","volume":"110","author":"Lin","year":"2002","journal-title":"J Clin Invest"},{"key":"2026093004085558200_aanag063-B13","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/S0002-9440(10)64268-X","article-title":"Deletion of decay-accelerating factor (CD55) exacerbates autoimmune disease development in MRL\/lpr mice","volume":"161","author":"Miwa","year":"2002","journal-title":"Am J Pathol"},{"key":"2026093004085558200_aanag063-B14","doi-asserted-by":"publisher","first-page":"3836","DOI":"10.4049\/jimmunol.172.6.3836","article-title":"Decay-accelerating factor deficiency increases susceptibility to dextran sulfate sodium-induced colitis: role for complement in inflammatory bowel disease","volume":"172","author":"Lin","year":"2004","journal-title":"J Immunol"},{"key":"2026093004085558200_aanag063-B15","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1084\/jem.20040863","article-title":"The complement inhibitory protein DAF (CD55) suppresses T cell immunity in vivo","volume":"201","author":"Liu","year":"2005","journal-title":"J Exp Med"},{"key":"2026093004085558200_aanag063-B16","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13075-015-0518-4","article-title":"CD55 deposited on synovial collagen fibers protects from immune complex-mediated arthritis","volume":"17","author":"Karpus","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"2026093004085558200_aanag063-B17","doi-asserted-by":"publisher","first-page":"106390","DOI":"10.1016\/j.rmed.2021.106390","article-title":"Genomic biomarkers in chronic beryllium disease and sarcoidosis","volume":"187","author":"Lin","year":"2021","journal-title":"Respir Med"},{"key":"2026093004085558200_aanag063-B18","doi-asserted-by":"publisher","first-page":"13282","DOI":"10.1038\/s41598-020-69281-8","article-title":"Novel protein pathways in development and progression of pulmonary sarcoidosis","volume":"10","author":"Bhargava","year":"2020","journal-title":"Sci Rep"},{"key":"2026093004085558200_aanag063-B19","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1084\/jem.184.3.1185","article-title":"The seven-span transmembrane receptor CD97 has a cellular ligand (CD55, DAF)","volume":"184","author":"Hamann","year":"1996","journal-title":"J Exp Med"},{"key":"2026093004085558200_aanag063-B20","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.4049\/jimmunol.177.2.1070","article-title":"Costimulation via CD55 on human CD4+ T cells mediated by CD97","volume":"177","author":"Capasso","year":"2006","journal-title":"J Immunol"},{"key":"2026093004085558200_aanag063-B21","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/s0165-5728(02)00306-5","article-title":"Expression of the EGF-TM7 receptor CD97 and its ligand CD55 (DAF) in multiple sclerosis","volume":"132","author":"Visser","year":"2002","journal-title":"J Neuroimmunol"},{"key":"2026093004085558200_aanag063-B22","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1002\/1529-0131(199904)42:4&lt;650::AID-ANR7&gt;3.0.CO;2-S","article-title":"Expression of the activation antigen CD97 and its ligand CD55 in rheumatoid synovial tissue","volume":"42","author":"Hamann","year":"1999","journal-title":"Arthritis Rheum"},{"key":"2026093004085558200_aanag063-B23","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1183\/13993003.01469-2015","article-title":"Beryllium-induced lung disease exhibits expression profiles similar to sarcoidosis","volume":"47","author":"Li","year":"2016","journal-title":"Eur Respir J"},{"key":"2026093004085558200_aanag063-B24","doi-asserted-by":"publisher","first-page":"215935","DOI":"10.1016\/j.canlet.2022.215935","article-title":"CD55 in cancer: complementing functions in a non-canonical manner","volume":"551","author":"Bharti","year":"2022","journal-title":"Cancer Lett"},{"key":"2026093004085558200_aanag063-B25","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.1164\/rccm.201409-1722ST","article-title":"An official American Thoracic Society statement: diagnosis and management of beryllium sensitivity and chronic beryllium disease","volume":"190","author":"Balmes","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"2026093004085558200_aanag063-B26","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/j.humimm.2014.10.010","article-title":"p38 mitogen\u2013activated protein kinase in beryllium-induced dendritic cell activation","volume":"75","author":"Li","year":"2014","journal-title":"Hum Immunol"},{"key":"2026093004085558200_aanag063-B27","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1084\/jem.20122426","article-title":"Identification of beryllium-dependent peptides recognized by CD4+ T cells in chronic beryllium disease","volume":"210","author":"Falta","year":"2013","journal-title":"J Exp Med"},{"key":"2026093004085558200_aanag063-B28","doi-asserted-by":"publisher","first-page":"3694","DOI":"10.4049\/jimmunol.1101872","article-title":"Mutagenesis of beryllium-specific TCRs suggests an unusual binding topology for antigen recognition","volume":"187","author":"Bowerman","year":"2011","journal-title":"J Immunol"},{"key":"2026093004085558200_aanag063-B29","doi-asserted-by":"publisher","first-page":"12717","DOI":"10.1073\/pnas.220430797","article-title":"Beryllium presentation to CD4+ T cells underlies disease-susceptibility HLA-DP alleles in chronic beryllium disease","volume":"97","author":"Fontenot","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026093004085558200_aanag063-B30","doi-asserted-by":"publisher","first-page":"35517","DOI":"10.18632\/oncotarget.21216","article-title":"Decreased expression levels of complement regulator CD55 contribute to the development of bullous pemphigoid","volume":"9","author":"Qiao","year":"2018","journal-title":"Oncotarget"},{"key":"2026093004085558200_aanag063-B31","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.cellimm.2010.07.013","article-title":"Expression of CD55 and CD59 on peripheral blood cells from systemic lupus erythematosus (SLE) patients","volume":"265","author":"Alegretti","year":"2010","journal-title":"Cell Immunol"},{"key":"2026093004085558200_aanag063-B32","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1265\/jjh.50.1077","article-title":"The changes of complement activities in sera of mice after subcutaneous administration of beryllium chloride [in Japanese]","volume":"50","author":"Sakaguchi","year":"1996","journal-title":"Nihon Eiseigaku Zasshi"},{"key":"2026093004085558200_aanag063-B33","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1265\/jjh.47.934","article-title":"A study of the humoral immunity of mice injected with beryllium chloride [in Japanese]","volume":"47","author":"Sakaguchi","year":"1992","journal-title":"Nihon Eiseigaku Zasshi"},{"key":"2026093004085558200_aanag063-B34","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/978-1-4419-7913-1_12","article-title":"The role of CD97 in regulating adaptive T-cell responses","volume":"706","author":"Spendlove","year":"2010","journal-title":"Adv Exp Med Biol"},{"key":"2026093004085558200_aanag063-B35","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1164\/rccm.201001-0025OC","article-title":"Deficient and dysfunctional regulatory T cells in the lungs of chronic beryllium disease subjects","volume":"181","author":"Mack","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"2026093004085558200_aanag063-B36","doi-asserted-by":"publisher","first-page":"e1004412","DOI":"10.1371\/journal.ppat.1004412","article-title":"Exploitation of the complement system by oncogenic Kaposi\u2019s sarcoma\u2013associated herpesvirus for cell survival and persistent infection","volume":"10","author":"Lee","year":"2014","journal-title":"PLoS Pathog"}],"container-title":["American Journal of Respiratory Cell and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrcmb\/advance-article-pdf\/doi\/10.1093\/ajrcmb\/aanag063\/68020269\/aanag063.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article-pdf\/74\/10\/1431\/68020269\/aanag063.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article-pdf\/74\/10\/1431\/68020269\/aanag063.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:09:10Z","timestamp":1790755750000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article\/74\/10\/1431\/8650646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,9]]},"references-count":36,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,4,9]]},"published-print":{"date-parts":[[2026,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ajrcmb\/aanag063","relation":{},"ISSN":["1535-4989"],"issn-type":[{"value":"1535-4989","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,4,9]]}}}